Effect of Dialyzer Reuse on Survival of Patients Treated with Hemodialysis

Published in: JAMA, Journal of the American Medical Association, v. 276, no. 8, Aug. 28, 1996, p. 620-625

Posted on RAND.org on January 01, 1996

by Harold I. Feldman, Monica Kinosian, Warren B. Bilker, Christopher W. Simmons, John H. Holmes, Mark V. Pauly, Jose J. Escarce

Dialysis in freestanding facilities reprocessing dialyzers with peracetic/acetic acid may be associated with worse survival than dialysis in freestanding facilities not reprocessing dialyzers or in those reprocessing with formaldehyde. The authors were unable to determine whether these relationships arose from greater comorbidity among patients treated in facilities using peracetic/acetic acid, poor quality of dialysis procedures in these facilities, or direct toxicity of peracetic/acetic acid. These findings raise important concerns about potentially avoidable mortality among U.S. hemodialysis patients treated in dialysis facilities reprocessing hemodialyzers.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.